XML 54 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Discontinued Operations
9 Months Ended
Sep. 30, 2014
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations
10.   DISCONTINUED OPERATIONS

On September 24, 2012, we completed the sale of our Visudyne business to Valeant pursuant to the Valeant Agreement. Under the terms of the Valeant Agreement, we received a payment of $112.5 million at closing and are also eligible to receive certain other contingent consideration, which is described under Note 3 — Contingent Consideration.

On April 3, 2013, we completed the sale of our PPDS Technology to Mati pursuant to the terms of an asset purchase agreement (the “Mati Agreement”). On December 24, 2012, we entered into an exclusive option agreement with Mati, under which we granted Mati a 90-day option to acquire assets related to our PPDS technology in exchange for $0.5 million. Upon receipt of this payment, we recorded it as deferred income and recognized the $0.5 million rateably into income over the 90- day option term in accordance with our obligation to maintain the related intellectual property during that period. In accordance with the terms of the Mati Agreement, we received an additional payment of approximately $0.8 million upon closing. Under the Mati Agreement, we are eligible to receive future potential payments upon completion of certain product development and commercialization milestones that could reach $19.5 million (or exceed that amount if more than two products are commercialized), a low single digit royalty on world-wide net sales of all products using or developed from the PPDS Technology and a fee on payments received by Mati in respect of the PPDS Technology other than net sales. Under the terms of the Mati Agreement, we do not have any significant ongoing involvement in the operations or cash flows related to the PPDS Technology other than minor transition services which we agreed to provide. The activities related to transition services were complete as at September 30, 2013.

 

The operating results related to our PPDS Technology and Visudyne business have been excluded from continuing operations and reported as discontinued operations for all periods presented:

 

                                                                               
       Three months ended        Nine months ended  
       September 30,        September 30,  
(In thousands of U.S. dollars)      2014        2013        2014        2013  
Recovery on assets held for sale (1)        —             37           —             212   
Operating pre-tax loss        (6        83           (63        (391
Gain on sale of discontinued operations (2)        —             —             —             743   
                                             
Pre-tax (loss) income        (6        83           (63        352   
                                             
Provision for income taxes        —             13           —             (236
                                             
Net (loss) income from discontinued operations      $ (6      $ 96         $ (63      $ 116   
                                             
                                             

 

(1) 

Relates to recoveries on equipment that was previously written down in connection with the sale of our PPDS Technology to Mati.

 

(2) 

Relates to the 2013 revenue recognition of funds received from Mati at the end of 2012, which were initially recorded as deferred income, for the 90-day option to acquire assets related to our former PPDS Technology.